One of the most frequently asked questions linked to the use of CBD and medical cannabis is, ‘will it ease my pain?’
While there’s no definitive answer yet, research into the subject so far is indicating a positive response, much to the relief of chronic pain sufferers across the world.
Here, Cannabis Health explores the most common chronic pain conditions cannabis may help with.
Thought to affect around one in 20 people, fibromyalgia is a long-term condition that causes pain all over the body, as well as other symptoms including headaches and muscle stiffening. There is currently no cure for the condition and those affected continue to look for new and alternative ways to manage their pain – with a recent US study finding that one third of fibromyalgia patients use medicinal cannabis for symptom relief.
A 2019 study of 367 patients supported this usage, finding that the remedy can reduce pain intensity. The team leading the research stated that “cannabis therapy should be considered to ease the symptom burden among those fibromyalgia patients who are not responding to standard care”.
Despite affecting at least one in ten women in the UK, endometriosis is a regularly misunderstood and misdiagnosed condition. Again, there is no cure for the condition, which is caused by tissue similar to the lining of the womb growing in other places and reacting to the menstrual cycle. Treatment is limited to painkillers and hormonal contraception, however in severe cases this can provide little relief – which is why more and more women are turning to CBD.
Results from women using the remedy are encouraging, with research supporting this and finding that cannabinoids such as CBD can stop endometrial cells from multiplying, reduce inflammation and desensitise nerves that transmit pain.
Multiple Sclerosis (MS)
A 2017 review from the MS Society found that 66% of people with MS surveyed had used cannabis to help with their symptoms, which can include muscle spasms, stiffness and chronic pain. As much-needed research and evidence to support these claims continues to grow, the number of MS patients turning to CBD is likely to have grown even further.
While still ongoing, research certainly seems to back up usage, with Rudroff and Sosnoff stating in a 2018 study: “It is our opinion that CBD supplementation may be advisable for PwMS (patients with MS) to reduce fatigue, pain, spasticity, and ultimately improve mobility.”
Arthritis is the most common cause of disability in the UK, with around 10 million people of all ages thought to be affected. However, despite a growing number of cases, most sufferers are left to self-manage pain and find their own methods of relief – such as CBD.
While no rigorous clinical studies in humans have been conducted to confirm the science behind the impact of CBD on arthritic pain so far, extensive positive reviews by users and results from animal studies are encouraging. For example, a 2017 study found that CBD might be a safe and useful treatment option for joint pain associated with osteoarthritis, while a 2016 review found that topical application of CBD had the potential to relieve pain and inflammation associated with the condition.
For sufferers of these conditions – as well as other illnesses causing chronic pain – CBD has been a welcome natural alternative for easing symptoms and reducing intensity, with ever-growing research only set to increase its popularity.
- Malta gives green light to three new cannabis clubs
- European Commission must address ‘inequality’ in access to medicinal cannabis across EU
- 1 in 8 older US adults now use cannabis products, finds study
- 3 main contributors to the entourage effect for cannabis consumers to consider
- Medical cannabis doesn’t impair cognitive function – study
- Ukraine’s medical cannabis legalisation delayed by opponents
- News4 months ago
NHS approves major clinical trial on cannabis medicines and chronic pain
- News6 months ago
UK patient secures first NHS reimbursement for cannabis flowers
- Advocacy6 months ago
Inside a UK cannabis club: changing lives, tackling stigma, building community
- News4 months ago
UK research finds GP support for cannabis as an alternative to opioids for chronic pain
- Industry4 months ago
‘Landmark’ ruling gives hope for UK CBD flower businesses
- Industry6 months ago
New report calls for overhaul of ‘discriminatory’ UK cannabis driving laws
- News4 months ago
Malta: Advocates emphasise positive effects of cannabis reform amid ‘normalisation’ concerns
- Science4 months ago
Five new cannabis studies – ALS, epilepsy, Parkinson’s, chronic pain and blood pressure